Illumina Claps Back At Carl Icahn

 
• By Barnaby Pickering

Carl Icahn has been causing trouble at the sequencing giant, using its muddied merger with Grail as justification for the nomination of three new board members of his choosing.

The bell will not sound in Icahn and Illumina's corporate boxing match until votes are counted. • Source: Shutterstock

More from Oncology

More from Device Area